35762 Federal Register / Vol. 61, No. 131 / Monday, July 8, 1996 / Notices

Analyte: Streptococcus, Group A (From

Throat Only) (5828)

Test System, Assay, Examination:

Quidel QuickVue In-Line One-Step Strep A

Test (25 test kit) (52036)

Speciality/Subspeciality: Endocrinology

Analyte: Ovulation Test (LH) by Visual Color

Comparison (9461)

Test System, Assay, Examination:

Quidel Conceive Ovulation Predictor

(52029)

Syntron Bioresearch BeSure OneStep

Ovulation Predictor Kit (58365)

Analyte: Urine HCG by Visual Color

Comparison Tests (9642)

Test System, Assay, Examination:

3C Diagnostics MIT One-Step Immediate

Pregnancy Test (01001)

AmeriTek One step dBest Dipstick (04661)

AmeriTek One step dBest Disk (04659)

AmeriTek One step dBest Midstream

(04660)

Applied Biotech SureStrip hCG Pregnancy

Test (04635)

Bionike A/Q Pregnancy Test (07636)

Boehringer Mannheim Accu-Stat hCG

(07710)

Excel Scientific OneStep Urine/Serum hCG

Preg Module Test (16133)

Horizon Diagnostics Pregna-Plus hCG

(25225)

Immunostics immuno hCG Detector

Pregnancy Test (28418)

Immunostics immuno hCG Detector Stix

(28417)

International Newtech Develop. MiniStrip

HCG ONESTEP (28394)

Johnson & Johnson CDI SureCell hCGUrine (31067)

Johnson & Johnson CDI SureCell hCGUrine/Serum (31066)

Medix Biotech CONTRAST hCG Urine/

Serum Test (40215)

Medix Biotech Rapid hCG (urine/serum)

(40224)

Mizuho USA Quick Checker hCG

Pregnancy Test (40207)

Quidel CAMEO Home Pregnancy Test

(52031)

Quidel CARDS Q.S. hCG (52032)

Quidel Concise Performance Plus hCG

(52033)

Sea-Band Pregnancy Test (58362)

Selfcare early Pregnancy test (test cassett)

(58401)

Selfcare early Pregnancy test (test stick)

(58400)

Simex Medical DiagnoStrip hCG (58397)

Syntron Platform OneStep Pregnancy Test

(58407)

Worldwide Medical First Check hCG

(cassette) (70181)

Worldwide Medical First Check hCG (test

stick) (70182)

Wyntek Diagnostics OSOM Pregnancy Test

for Home Use (70175)

Wyntek Diagnostics OSOM hCG-Combo

Test (70177)

Wyntek Diagnostics OSOM hCG-Urine Test

(70174)

Speciality/Subspeciality: General

Chemistry

Analyte: Body Fluids (Other Than Blood) pH

(0731)

Test System, Assay, Examination:

All Qualitative Color Comparison pH

Testing (04542)

Analyte: Cholesterol (1020)

Test System, Assay, Examination:

Boehringer Mannheim Accu-Chek

InstantPlus Cholesterol (07776)

ChemTrak AccuMeter (10165)

Cholestech L.D.X. (10170)

Johnson & Johnson ADVANCED CARE

Cholesterol Test (31014)

Analyte: Fecal Occult Blood (9191)

Test System, Assay, Examination:

Dipro Diagnostics Hemdetect (13308)

Immunostics hema screen (28419)

Analyte: Gastric Occult Blood (2211)

Test System, Assay, Examination:

SmithKline Gastroccult (58217)

Analyte: Glucose (2203)

Test System, Assay, Examination:

Cholestech L.D.X. (10170)

HemoCue B-Glucose System (25112)

Analyte: Glucose Monitoring Devices (FDA

Cleared/Home Use) (9221)

Test System, Assay, Examination:

Bayer GLUCOMETER ELITE Blood Glucose

Meter (07685)

Bayer GLUCOMETER ENCORE QA+ Blood

Glucose Meter (07689)

Chronimed Supreme Blood Glucose Meter

(10315)

Chronimed Supreme Blood Glucose Test

Strips (10316)

Johnson & Johnson Lifescan ONE TOUCH

II Bld Glucose Monitor (31017)

Johnson & Johnson Lifescan ONE TOUCH

II Glucose Test Strips (31018)

LifeScan ONE TOUCH Profile Complete

Diabetes Tracking Sys. (37101)

Lifescan SureStep Blood Glucose

Monitoring System (37090)

MediSense MediSense 2 Blood Glucose

Testing System (40214)

MediSense Precision QID Blood Glucose

Testing System (40213)

Analyte: HDL Cholesterol (2550)

Test System, Assay, Examination:

Cholestech L.D.X. (10170)

Analyte: Microalbumin (4019)

Test System, Assay, Examination:

Boehringer Mannheim Chemstrip Micral

(urine dipstick) (07717)

Analyte: Triglyceride (6118)

Test System, Assay, Examination:

Cholestech L.D.X. (10170)

Speciality/Subspeciality: Hematology

Analyte: Erythrocyte Sedimentation Rate,

Nonautomated Waived (9161)

Test System, Assay, Examination:

Becton Dickinson SedItainer ESR System

(07694)

Analyte: Spun Microhematocrit (9581)

Test System, Assay, Examination:

StatSpin Technologies CritSpin (58368)

Vulcon Technologies Microspin 24 (67098)

Speciality/Subspeciality: Urinalysis

Analyte: Urine Dipstick or Tablet Analytes,

Nonautomated (9641)

Test System, Assay, Examination:

Chemtech Labs URISTRIP (10294)

Genesis Labs DIA SCREEN Urine Reagent

Strips (22176)

TECO Diagnostics Urine Reagent Strips 1

(61151)

TECO Diagnostics Urine Reagent Strips 8

(61187)

TECO Diagnostics Urine Reagent Strips 9

(61219)

Announcement of Boards Approved by

HHS

In the personnel regulations at

§ 493.1443(b)(3)(i), individuals with an

earned doctoral degree in a chemical,

physical, biological or clinical

laboratory science and certification by a

board approved by HHS may qualify as

a laboratory director. Under

§ 493.1455(a), individuals who meet the

director qualification requirements of

§ 493.1443(b)(3)(i) may qualify as a

clinical consultant. Under these

provisions, four boards have been

approved by HHS, and HHS has

authority to recognize any certification

board having comparable requirements.

The American Board of

Histocompatibility and Immunogenetics

(ABHI) and the American Board of

Medical Genetics (ABMG) applied for

approval and submitted documentation

on the education, training and

experience required for certification.

Both boards were determined to have

credentialing requirements comparable

to the boards currently approved by

HHS, and ABHI and ABMG were

subsequently notified that they meet

CLIA requirements for board approval.

In this Notice we are announcing HHS

approval of ABHI and ABMG

certification to qualify individuals as

laboratory directors and clinical

consultants under the CLIA regulations.

Individuals with a doctoral degree in a

chemical, physical, biological or clinical

laboratory science and certification by

ABHI or ABMG meet the CLIA

qualification requirements to serve as a

laboratory director or clinical

consultant.

[FR Doc. 96–17097 Filed 7–5–96; 8:45 am]

BILLING CODE 4163–18–P
Federal Register / Vol. 61, No. 131 / Monday, July 8, 1996 / Notices 35763

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Cooperative

Agreements for STD Faculty

Expansion, Program Announcement

616; Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

NAME: Disease, Disability, and Injury

Prevention and Control SEP:

Cooperative Agreements for STD

Faculty Expansion, Program

Announcement 616.

TIME AND DATE: 8:30 a.m.–5 p.m., August

8, 1996.

PLACE: 11 Corporate Square, Building

11, Conference Room A, Corporate

Square Boulevard, Atlanta, Georgia

30329.

STATUS: Closed.

MATTERS TO BE DISCUSSED: The meeting

will include the review, discussion, and

evaluation of applications received in

response to Program Announcement

616.

The meeting will be closed to the

public in accordance with provisions set

forth in 5 U.S.C. 552b(c) (4) and (6), and

the Determination of the Associate

Director for Management and

Operations, CDC, pursuant to Pub. L.

92–463.

CONTACT PERSON FOR MORE INFORMATION:

John R. Lehnherr, Chief, Prevention

Support Office, National Center for HIV,

STD, and TB Prevention, CDC, 1600

Clifton Road, NE, M/S E07, Atlanta,

Georgia 30333, telephone 404/639–

8025.

Dated: July 1, 1996.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 96–17220 Filed 7–5–96; 8:45 am]

BILLING CODE 4163–18–M

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: The Office of Child Support

Enforcement OCSE–156 Child Support

Enforcement Program Quarterly Data

Report and OCSE–158 Child Support

Enforcement Program Annual Data

Summary Report.

OMB No.: 0970–0057.

Description: The authority to collect

and report the information requested on

these forms is found in sections

452(a)(4), 452(a)(5), 452(a)(10), and 469

of the Social Security Act. These data

are highly aggregated used in a

management function to establish the

effectiveness and efficiency of State

child support programs. The Federal

Office of Child Support Enforcement

will use the data to carry out its

oversight role and submit the Annual

Report to Congress.

Respondents: State governments.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses

per respondent

Average

burden

hours per

response

Total burden hours

OCSE–156 ........................................................................................................................ 54 4 3.7 799.2

OCSE–158 ........................................................................................................................ 54 1 1.2 64.8

Estimated Total Annual Burden Hours:

864.0.

In compliance with the requirements

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

Division of Information Resource

Management Services, 370 L’Enfant

Promenade, S.W., Washington, D.C.

20447, Attn: ACF Reports Clearance

Officer. All requests should be

identified by the title of the information

collection.

The Department specifically requests

comments on: (a) whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden on the collection of information

on respondents, including through the

use of automated collection techniques

or other forms of information

technology. Consideration will be given

to comments and suggestions submitted

within 60 days of this publication.

Dated: June 27, 1996.

Larry Guerrero,

Director, Office of Information Services.

[FR Doc. 96–17190 Filed 7–5–96; 8:45 am]

BILLING CODE 4184–01–M

New and Pending Demonstration

Project Proposals Submitted Pursuant

to Section 1115(a) of the Social

Security Act: June 1996

AGENCY: Administration for Children

and Families, HHS.

ACTION: Notice.

SUMMARY: This notice lists new

proposals for welfare reform and

combined welfare reform/Medicaid

demonstration projects submitted to the

Department of Health and Human

Services for the month of June, 1996. It

includes both those proposals being

considered under the standard waiver

process and those being considered

under the 30 day process. Federal

approval for the proposals has been

requested pursuant to section 1115 of

the Social Security Act. This notice also

lists proposals that were previously

submitted and are still pending a

decision and projects that have been

approved since June 1, 1995. The Health

Care Financing Administration is

publishing a separate notice for

Medicaid only demonstration projects.

COMMENTS: We will accept written

comments on these proposals. We will,

if feasible, acknowledge receipt of all

comments, but we will not provide

written responses to comments. We

will, however, neither approve nor

disapprove new proposals under the

standard application process for at least

30 days after the date of this notice to

allow time to receive and consider